Who Owns USANA Health Sciences, Inc. Company?

USANA Health Sciences, Inc. Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Owns USANA Health Sciences?

Ever wondered about the driving forces behind a global wellness giant like USANA Health Sciences? The USANA Health Sciences, Inc. SWOT Analysis reveals that understanding its ownership structure is key. From its humble beginnings to its current status as a publicly traded company, the story of USANA's ownership is a fascinating journey of growth and transformation.

Founded by Dr. Myron Wentz in 1992, USANA Health Sciences has evolved significantly since its IPO in 1996. This exploration into USANA ownership will uncover the shifts in its shareholder base, from the influence of the USANA founder to the current mix of institutional and individual investors. Understanding who owns USANA provides critical insights into the company's strategic direction, governance, and market position, answering questions like: Who are the major shareholders of USANA and how does this impact the company's future?

The origins of USANA Health Sciences trace back to 1992, when Dr. Myron Wentz established the company. Dr. Wentz, a microbiologist and immunologist, brought a strong scientific foundation to the venture. His prior experience with Gull Laboratories, a diagnostic testing company founded in 1974, provided him with valuable entrepreneurial experience.

Dr. Wentz's vision for USANA centered on the multi-level marketing of nutritional supplements. This approach, which remains a key aspect of the business model, was established from the company's inception. The company's focus on direct selling was a strategic decision made by the founding team.

While Dr. Wentz is recognized as the founder, key figures like Dallin A. Larsen also played important roles in the early days. Larsen served as Vice President of Sales starting in 1993 and later as a consultant. The company's initial ownership structure and specific shareholding details during the founding phase are not publicly available beyond Dr. Wentz's foundational role.

Founding Vision

Dr. Myron Wentz founded USANA with a focus on nutritional supplements.

Early Leadership

Dallin A. Larsen was a key figure in sales and later as a consultant.

Business Model

USANA adopted a multi-level marketing strategy from the beginning.

Founder's Background

Dr. Wentz's background in microbiology and immunology was crucial.

Prior Venture

Dr. Wentz previously founded Gull Laboratories in 1974.

Direct Selling

The direct selling model was a core component of the company's strategy.

Key Takeaways

Understanding the and the company's history is crucial for investors. Dr. Myron Wentz's role as the and the early adoption of the multi-level marketing model are fundamental to the company's identity. The company's structure and the contributions of key figures like Dallin A. Larsen shaped the business. The company is a publicly traded company, and the stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol USNA. As of May 2024, the company's market capitalization is approximately $1.2 billion.

• Dr. Myron Wentz founded USANA in 1992.
• Dallin A. Larsen was a key early leader in sales.
• The multi-level marketing model was adopted from the start.
• USANA is a publicly traded company.

USANA Health Sciences, Inc. SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The evolution of USANA Health Sciences, Inc.'s ownership structure has been significantly shaped by key events. The company went public in 1996, listing on the NASDAQ under the ticker symbol USNA. This move provided capital for growth and increased public visibility. Later, in 2011, the company transitioned its listing to the New York Stock Exchange (NYSE).

As of May 30, 2025, USANA Health Sciences, Inc. had a market capitalization of $556.27 million. This reflects the company's value as determined by the stock market and is a key indicator of its financial health and investor confidence. Understanding the ownership structure is crucial for investors and stakeholders interested in the company's performance and strategic direction.

The ownership of USANA is primarily distributed among institutional investors, company insiders, and the general public. As of June 4, 2025, there are 405 institutional owners and shareholders who have filed with the SEC, collectively holding a total of 13,590,827 shares. This represents approximately 72.98% of institutional shares. Key institutional shareholders include BlackRock, Inc., and Vanguard Group Inc. The founder, Myron Wentz, holds a significant portion of the shares among insiders. For more details on the company's approach, consider reading about the Marketing Strategy of USANA Health Sciences, Inc.

Key Takeaways on USANA Ownership

USANA is a publicly traded company with a significant portion of its shares held by institutional investors.

• Institutional investors hold a substantial majority of the shares.
• Company insiders, including the founder, maintain a notable stake.
• The public holds the remaining shares.
• Understanding the ownership structure is crucial for investors.

USANA Health Sciences, Inc. PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

As of May 20, 2025, the board of directors of USANA Health Sciences, Inc. comprises eight members. The current board includes Kevin G. Guest, serving as Executive Chairman, and Jim Brown as the Chief Executive Officer and President. Other members include Myron Wentz, Xia Ding, John T. Fleming, Gilbert A. Fuller, J. Scott Nixon, Peggie Pelosi, and Frederic J. Winssinger. Six of the eight board members are independent directors, ensuring a balance of perspectives.

Gilbert A. Fuller, a director since September 2008, chairs the Audit Committee and Governance, Risk & Nominating Committee, and is also a member of the Compensation Committee. Xia Ding, who joined in October 2021, brings expertise in e-commerce and digital business. The board's average tenure is 6.1 years, indicating a seasoned group. For more insights into the competitive environment, you can explore the Competitors Landscape of USANA Health Sciences, Inc.

The company operates with a standard one-share-one-vote structure, with founder Myron Wentz holding a significant ownership stake. There have been no recent proxy battles or activist investor campaigns publicly disclosed. This structure and the composition of the board influence the company's strategic direction and operational decisions.

Key Takeaways on USANA Ownership and Governance

The board of directors includes experienced members, with a majority of independent directors. The founder's ownership provides significant influence. Understanding the board's composition is crucial for assessing the company's strategy.

• Board consists of eight members as of May 2025.
• Six of the eight board members are independent.
• Myron Wentz, the founder, holds a notable ownership stake.
• The average tenure of the board of directors is 6.1 years.

USANA Health Sciences, Inc. Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the past few years, USANA Health Sciences has seen significant shifts in its ownership structure and strategic direction. A major development was the acquisition of a 78.8% controlling interest in Hiya Health Products, LLC, completed on December 23, 2024, for $205 million. This move is expected to boost USANA's 2025 adjusted EBITDA and broaden its reach in the direct-to-consumer market. Hiya's sales reached $103 million for the twelve months ending September 30, 2024, with projected growth of approximately 30% year-over-year for fiscal year 2025.

In terms of capital management, USANA has been active in share repurchase programs. As of December 28, 2024, the company had roughly $61.7 million available for share repurchases. The company repurchased and retired shares totaling $9.4 million in 2024. In Q1 2025, USANA spent $12 million on share repurchases, with $49 million remaining in its program. Leadership changes have also occurred, with Kevin Guest becoming Executive Chairman of the Board in July 2023, and Jim Brown taking over as President and Chief Executive Officer.

Myron Wentz, the USANA founder, retired from his position as Chairman of the Board and director at the May 1, 2020, Annual Shareholder Meeting, transitioning to Chairman Emeritus. Industry trends show an increase in institutional ownership, with USANA having 405 institutional owners as of June 4, 2025, holding over 13.5 million shares. The fiscal year 2025 outlook anticipates consolidated net sales between $920 million and $1.0 billion, representing 8% to 17% growth. The company continues to explore acquisition opportunities and investments in complementary ventures.

USANA Ownership Overview

The ownership of USANA Health Sciences is a mix of institutional investors, insiders, and the public. Understanding the ownership structure can provide insights into the company's stability and strategic direction. Key figures and entities hold significant stakes in the company.

Recent Acquisitions and Investments

USANA has made strategic moves to expand its market presence, such as the acquisition of Hiya Health Products. These investments signal the company's commitment to growth. The company is actively looking for complementary ventures in the health and wellness sector.

Leadership and Executive Changes

Leadership transitions have occurred, with Kevin Guest moving to Executive Chairman and Jim Brown becoming CEO. These changes reflect the company's adaptability. The founder, Myron Wentz, remains involved in a Chairman Emeritus role.

Financial Performance and Outlook

USANA's financial outlook for fiscal year 2025 projects strong growth. The company's continued focus on share repurchases indicates confidence in its financial health. The company's net sales are expected to be between $920 million and $1.0 billion.

USANA Health Sciences, Inc. Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs